Kolbeck Dental announced an upcoming virtual hands-on webinar that it calls "Webinar in a Box," covering complete dentures and featuing the OMP tool. 

Participants will receive by mail a box full of materials, including an OMP tool, edentulous models, pencil, Ivoclar Vivadent denture teeth, and a study model to perform a complete upper denture setup as a waxup.

The webinar will go step by step utilizing the OMP. It will be held on on request, with specific dates depending on booking.

To register and for more details, contact kolbeckdental@gmail.com.

Is a less painful dental injection worth more money? The vast majority of dental patients think so. More than 7 out of 10 patients said they’d pay extra if their dentist used a faster, less painful local anesthetic, according to a new survey from dental pharmaceutical company Balanced pHarma.

Balanced pHarma published the results of its online survey on July 28 that asked dozens of dental patients about their experiences with dental procedures and whether they’d be willing to shell out extra cash for less painful injections.

More than 7 out of 10 dental patients said they’d be willing to pay extra if their dentist used a faster, less painful anesthetic, and more than half were willing to pay at least 10% more for the procedure.

Not surprisingly, respondents were even more concerned about injection pain when asked about a child or loved one, with 9 out of 10 patients willing to pay extra and three-fourths willing to pay at least 10% more for the procedure.

”The survey responses were a wonderful reminder of just how much people care about others,” said Dr. Scott Keadle, Chief Medical Officer at Balanced pHarma. “Clearly, people want dental injections to be less painful, but they really want their loved ones to have less painful injections.”

A majority of patients reported that painful injections were the thing they feared most about a dental visit. This could be why more than one-third said they would switch dentists to find one that offered a less painful anesthetic option.

“These survey findings show that dental practices might be able to help patients and save time by offering a buffered local anesthetic,” Keadle added.

Other survey findings:

● Fear of injections kept 12% of patients from visiting the dentist as often as they should.

● A painless injection was a “must-have when selecting a dentist” for 47% of respondents.

Buffered anesthetics cause less pain

The survey findings make it clear that a large majority of dental patients want a less painful dental injection, and buffered anesthetics offer one way to achieve this.

Research shows that neutralizing the acidity of local anesthetics (buffering) makes the pH-balanced drugs less toxic¹, less painful², faster acting³, and more likely to achieve successful anesthesia4 than conventional injections.

Buffered anesthetics improve productivity

With quicker onset times and more reliable anesthesia, pH-balanced anesthetics also offer more efficiency for dental service providers. Balanced Pharma crunched the numbers and found practices could raise productivity by 12%.

“pH-balanced anesthetics not only help patients survive the injection, but they also give clinicians a faster-acting and more reliable drug that increases productivity,” Keadle said.

About Balanced pHarma and Libracaine

Balanced pHarma, with headquarters in Cornelius, North Carolina, is a medical and dental pharmaceutical company that develops better local anesthetic drugs to improve patient comfort and safety.

Libracaine is a new pH-balanced (buffered) anesthetic that doesn’t cause pain on injection and works much faster than traditional anesthetics. Unlike other buffered anesthetic products, Libracaine will be offered in a standard dental cartridge that can be used in a standard dental syringe. It will also cost about two thirds less than the current buffered products.

Libracaine is currently in development and not approved by the U.S. Food and Drug Administration for sale or distribution.

Learn more at BalancedPharma.com.

About the Survey

In May 2020, Balanced pHarma conducted an informal online survey of 92 dental patients. The survey asked participants about their dental office experiences, including what they found most fearful about visiting the dentist and how they feel about dental injections.

References:

1. Warren, et al, J Oral Maxillofac Surg 75:1363-1366, 2017

2. Guo, et al, J Dent Anesth Pain Med 2018;18(3):129-142

3. Malamed, Falkel, et al, Compendium, Feb 2013; Vol. 34:1, pp. 10-20

4. Kattan, et al, JADA 2019:150(3):165-177

Sonendo®, Inc., a leading dental technology company and developer of the GentleWave® System, today announced that the GentleWave System creates virtually no aerosols during root canal treatment.

Even prior to the COVID-19 pandemic, dentistry had a good track record in infection control. Practices typically use state-of-the-art safeguards to protect their patients, such as rubber dams that limit aerosol emission during treatment and personal protective equipment (PPE). Healthcare agencies such as the American Association of Endodontists (AAE), American Dental Association (ADA) and the Centers for Disease Control (CDC) have called for additional measures in light of the SARS-CoV-2 virus. As a result, many practices have adopted measures such as extra PPE, more frequent cleaning of treatment rooms, new air filtration and social distancing.

According to CDC, some endodontic instruments create a visible spray that can contain particle droplets of water, saliva, blood, microorganisms, and other debris. The GentleWave System releases virtually no aerosolized material into the air during normal use as it is a closed-loop system, which is a significant benefit to patients, clinicians, and their staff. Additionally, the procedure is generally performed in one visit². This not only minimizes the inconvenience but also reduces patients' exposure to COVID-19. Most patients find the procedure to be comfortable and report minimal to no pain after the procedure³. Procedure instruments for the GentleWave System also come pre-sterilized and are single use, hence minimizing the risk of exposure from one patient to the next.

"The GentleWave procedure offers the latest advancement in root canal therapy. It provides efficient cleaning and disinfection of the smallest spaces in the teeth, this allows us to deliver an optimal root canal experience for our patients," said Dr. Mark Limosani, DMD, Endodontics Practitioner in Weston, FL. "During this time while patients may be concerned about COVID-19, it also minimizes their time in our office, and therefore the potential for viral exposure."

"We designed the GentleWave System with the patient in mind. We wanted to bring patient care and outcomes to a new level by improving cleaning and disinfection of the root canal system. We are excited that this System also provides benefits in the COVID-19 environment by virtually eliminating the emission of aerosols and hence, reducing the risk of virus exposure to both patients and providers," said Bjarne Bergheim, President and CEO of Sonendo.

ABOUT THE GENTLEWAVE PROCEDURE

The GentleWave System provides novel approach to root canal treatment. By using broad-spectrum sound waves, advanced fluid dynamics and accelerated chemistry, the System helps deliver optimal cleaning and disinfection to the entire root canal system⁴. Unlike standard root canal treatments, the procedure is able to reach throughout the tooth—even in the microscopic places where bacteria can hide - and leaves more of the tooth structure intact^4,6. The GentleWave System produces virtually no aerosols as it is closed-loop and the procedure is performed with a single-use, sterilized instrument, which eliminates the risk of cross-contamination. For most patients, the procedure can be performed in a single visit, which reduces the risk of exposure to virus and improves convenience, with minimal to no pain post-procedure.

For more information about the GentleWave Procedure, please visit www.GentleWave.com

ABOUT SONENDO

Sonendo, Inc. is a privately held company developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment^5,6,7. Sonendo is the parent company of TDO® Software, the developer of the most widely used endodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.

For more information about Sonendo visit www.sonendo.com . For information about TDO visit www.tdo4endo.com

REFERENCES

1. Data on file at Sonendo; internal testing report# TR20-002

2. Sigurdsson et al. J Endod 2018; 44(3):510-517

3.  Sigurdsson et al. J Endod 2016; 41(7):1040-10484

4. Vandrangi P et al. (2015) Oral Health 72-86 2

5. Sigurdsson A et al. (2016) J Endod. 42:1040-48.

6. Molina B et al. (2015) J Endod. 41:1701-05.

7. Trope M et al. (1999) J Endod. 25:345–50

Neocis, Inc., the leader and pioneer in robot-assisted dental implant surgery, announced today that they have received 510(k) clearance from the US Food and Drug Administration (FDA) for a new Yomi® edentulous indication. The clearance allows for a new splint attachment which broadens Yomi’s application to include full arch implant cases as well as partially edentulous cases. The American College of Prosthodontists estimates that over 36 million Americans are missing all their teeth. The new Yomi edentulous splint will enable doctors to use Yomi’s technology to reach more of this population.

“I am delighted today to report that we have received 510(k) clearance for Yomi to assist with full arch implant surgeries. With this clearance, Yomi doctors will be able to leverage robotic technology to treat more patients and restore more smiles,” said Alon Mozes, PhD, Chief Executive Officer of Neocis.

Uday Reebye, MD, DMD, a leader in Oral and Maxillofacial Surgery with a practice in Durham, NC, was an investigator in the clinical study that supported the FDA clearance. He said, “The advent of Yomi’s full arch protocol is a dramatic shift in dental implant surgery. A reduction in time to surgery, improved surgical efficiency, and accuracy, combined with a minimally invasive approach, have made Yomi’s full arch protocol the gold standard. Using Yomi, I was able to complete full arch surgery on average in 21 minutes.”

Scotty Bolding, DDS, MS, a renowned oral surgeon who practices in both Fayetteville, AR, and St. Petersburg/ Tampa Bay, FL, was also an investigator in the clinical study. He said, “I was so impressed by the accuracy of the first cases using Yomi robotic guidance in fully edentulous patients. The splints were extremely stable, easy to use, and remarkably accurate. Additionally, there was excellent visibility in the surgical field that you cannot get with any available guide today. There is no doubt in my mind that Yomi will set the standard for the multi-implant cases in the future. I have been placing dental implants for over 30 years, and I have never experienced the precision or accuracy that was demonstrated with the new full arch splint.”

About Yomi

Yomi® is the first and only FDA-cleared robot-assisted dental surgery system. Yomi is a computerized navigational system intended to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides navigational guidance of the surgical instruments. Yomi is intended for use in partially edentulous and fully edentulous adult patients who qualify for dental implants. The system offers precise and accurate physical guidance through haptic robotic technology, which constrains the drill in position, orientation, and depth. The assistive technology provides the surgeon with complete control and, unlike plastic surgical guides, allows for clear visualization of the surgical site. Yomi can be used for flapless dental implant procedures, which is a type of minimally invasive surgical approach. A minimally invasive flapless surgical approach has been proven to lead to faster surgery, faster recovery, and less pain for the patient. The Yomi Robotics system has been used to place over 2000 dental implants across the United States.

About Neocis, Inc.

Neocis Inc. is a private company located in Miami, Florida that is transforming dental surgery with advanced robotics, with a vision of advancing healthcare through the latest technology. Neocis manufactures and markets Yomi®, the first and only robot-assisted surgical platform for the dental industry. Neocis is venture-backed, including funding from Mithril Capital Management, Norwest Venture Partners and robotic surgery industry pioneer Fred Moll. For more information visit www.Neocis.com.

CHARLOTTE, NC (July 28, 2020) – Dentsply Sirona, the world’s largest manufacturer of professional dental products and technologies, announced today that Dentsply Sirona World 2020 will be reimagined into dynamic localized in-person and globally-available virtual events. The

new formats – certain to delight attendees – will offer expanded opportunities for earning CE credit and feature the best and brightest speakers in dentistry presenting engaging educational sessions across 12 unique tracks. The in-person program originally scheduled October 1-3, 2020 in Las Vegas, NV will be postponed to a later date.

“The current circumstances prevent an event the size and quality of Dentsply Sirona World to take place in person,” said Senior Vice President Eric Bruno. “Though we are postponing the event in Las Vegas, the localized in-person programs and the new and expanded virtual event will be packed with the same great content expected of The Ultimate Dental Meeting presented in a new, innovative forum. We are taking a stand that dentistry is essential and that digital dentistry is the future, so we are doubling down on our digital efforts for Dentsply Sirona World and

complementing those with localized in-person programming in collaboration with our industry partners.”

At its core, Dentsply Sirona World is a celebration of dentistry combining incredible professional development courses, ample opportunities to connect and network with thousands of dental professionals and world-class entertainment in an exciting, inspiring atmosphere. The online event will feature a full program with a general session and cutting-edge breakouts tailored to individual needs, with introductory to expert-level courses ranging from specialties such as implantology, to laboratory courses, to hygiene topics.

“The Dentsply Sirona World 2020 localized in-person programs and virtual event will bring an exceptional experience to attendees, with our continued commitment for delivering healthy smiles through healthy practices” added Bruno. “The virtual and local in-person programs will

allow attendees to interact with our speakers, products and latest technologies in an entirely new way while continuing to shape the future of dentistry.”

The specific dates and more details of the localized in-person programs and the virtual Dentsply Sirona World event will be announced in the coming weeks.

Everyone already registered for Dentsply Sirona World 2020 receives registration for the virtual program; no action is required on registered attendees’ part to register for the virtual program. Current registrations for the in-person Dentsply Sirona World 2020 will automatically transfer to the new in-person 2021 date when it is announced. Additional details regarding the virtual event will be forthcoming in the next few weeks. For updates and announcements regarding the virtual Dentsply Sirona World program, visit www.dentsplysironaworld.com often.

Arfona, a leader in 3D printing and digital technology for dental applications, has announced the opening of its state-of-the-art 3D printing service bureau. The 3D manufacturing facility and testing laboratory is part of a joint venture between Arfona, LLC, and Valplast International Corp. and operates under the name Arfona Printing Services. Funding for the venture was provided by RFC Capital Partners Fund 3, LLC.

First announced in February at the Chicago LMT Lab Day, the design and construction of the facility took place during some of the most challenging months for the Northeast in recent history given the regional shutdown that was in place as a result of the COVID-19 pandemic. 

“Although the quarantine provided many challenges for everyone, we decided to use the opportunity to maximize our downtime and push forward with the company expansion,” says Justin Marks, CDT, founder and CEO of Arfona, LLC. “We are happy to report that our new 3D printing center is now fully operational and open for business.”

Arfona Printing specializes in 3D printed Valplast Flexible Partials, utilizing additive manufacturing and post-processing technologies that the company developed in collaboration with Valplast International Corp. over the past decade. Laboratories can send a model scan or digital impression and Arfona will design, print, and finish a Valplast partial in 3-4 days. Valplast digital design services are also available for labs who already own the Arfona r.Pod 3D printer. In addition to 3D printed Valplast partials, Arfona Printing also offers 3D printed denture try-ins, custom impression trays, and digital models for removable and orthodontic applications. 

Dental laboratories can send their cases through the Arfona Printing online portal, by email, or through 3Shape Communicate. More information can be found on the company’s website at www.arfonaprinting.com.

Taking into account all the different factors for its customers and employees and following intensive discussions, Dentsply Sirona has decided the Company will not attend the International Dental Show (IDS), scheduled to be held from March 9th to 13th, 2021 in Cologne, Germany. This also applies to Dentsply Sirona brands VDW, MIS and Zhermack.

Current estimates indicate that the expected restrictions due to the COVID-19 pandemic in March 2021 will almost certainly not allow the proximity and depth of consultation that Dentsply Sirona and its customers know and value.

In particular, this environment would mean that customer meetings, interactions and consultations would not have their usual quality. Dentsply Sirona also believes that travel conditions will result in significantly fewer national and, especially, international visitors attending the IDS. The company puts the safety of its customers and employees first when making these types of decisions.

Walter Petersohn, Chief Commercial Officer at Dentsply Sirona, says, "It was a difficult decision to make, but much of what makes the IDS and its unique dynamics what they are, will not be possible in March 2021 because of the conditions we expect due to COVID-19. We would not be able to provide our customers and visitors with their usual experience at the show at this time. The same applies to the quality that they expect of Dentsply Sirona. We trust that the situation will change in due course, and we already look forward to taking part in the next IDS." 

ABOUT DENTSPLY SIRONA

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarter is located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

2C MedTech, a healthcare product developer and distributor specializing in commercializing real innovations with true impact, is partnering with CASPR™ Group to introduce CASPR’s next generation disinfection technology to dental offices across the globe.

Previously only available to hospitals as an in-duct HVAC product, CASPR Medik™ is now available to dental offices as an HVAC solution as well as a new portable unit called CASPR Compact Medik.

CASPR, which stands for Continuous Air and Surface Pathogen Reduction was originally developed for hospitals, to reduce the risk of Healthcare Associated Infections (HAIs). Given the heightened awareness of the risk to dental professionals from Aerosol Generating Procedures, CASPR chose to make the CASPR Medik products available to dental offices.

At the heart of the CASPR system is its Medik disinfection technology which reacts with the H2O molecules found in the air to continuously create highly effective oxidizing molecules such as hydrogen peroxide (H2O2).

These molecules are delivered at safe levels to reduce clinically relevant pathogens, including viruses. CASPR is safe for use in occupied space and does not interrupt patient care.

“CASPR Medik is a great option for dental offices concerned with reducing air and surface pathogens.” says 2C MedTech CEO, Lea Ellermeier. “The new CASPR Compact Medik is plug and play. it is easy to install and virtually silent.”

According to practicing dentist and CDC consultant Dr. Margaret Scarlett, “When it comes to controlling pathogens associated with dental aerosols, CASPR Medik technology can be a highly-effective first line of defense.”

The main benefits of CASPR Medik technology include the following:

• Up to 99.96% kill rate of bacteria, viruses, and molds on surfaces

• Provides continuous air and surface protection

• Safe for use in occupied spaces like waiting rooms and operatories

• Proven to be highly effective against pathogens, odors, and VOCs

The mobile version of the technology, CASPR Compact Medik, is small, portable, and easy to deploy where needed in dental offices of all sizes. Each unit can cover an area up to 1,500 square feet and has a list price of $1,850. The product is available for pre-order and is expected to ship mid-August. CASPR in-duct units are priced according to the square footage of the area where they are deployed. Both versions of CAPR Medik can be ordered at www.2cmedtech.com.For more details on the science behind the CASPR and how it compares to other infection control technologies, download the free whitepaper “The Role of Air Disinfection in Mitigating the Risks of Aerosol Generating Procedures” by visiting https://2cmedtech.com/caspr/caspr-compact-medik .

About 2C MedTech:

With U.S. headquarters in Dallas, Texas, 2C MedTech is a wholly owned subsidiary of 2C Dental AG. The Company also operates under the name 2C Dental Technologies Inc. The Company is led by a team of experienced medical device entrepreneurs, inventors and clinicians who have launched disruptive technology products in the United States, Europe, and Asia.

In 2020, 2C MedTech became the CASPR Group’s representative to the dental market, bringing Continuous Air and Surface Pathogen Reduction to dental practices throughout the United States. In 2019 the company developed the 2CLEAR™ System for Aesthetic Orthodontics, a new hybrid approach that combines the world’s thinnest, most aesthetic orthodontic bracket that doubles as an aligner attachment during aligner therapy. For more information, visit www.2CMedTech.com.

Leading dental support organization (DSO) Pacific Dental Services (PDS®) will once again join forces with The Smile Generation® to launch the 10th annual Smile Generation Serve Day, an annual day of service and a nationwide campaign of giving that focuses on providing donated dentistry to underserved patients. On Saturday, August 15th, hundreds of PDS-supported dental practices and volunteers throughout the United States will provide thousands of patients with comprehensive oral health care, including cleanings, x-rays, scaling and root planing, restorations and extractions, if needed. Since its inception in 2011, more than 18,000 patients have received donated dentistry during Smile Generation Serve Day, totaling $32 million in oral health care.

“Service is at the heart of who we are as an organization,” said Kyle Guerin, Director, PDS Foundation and Corporate Social Responsibility. “Every day, the dentists supported by Pacific Dental Services answer the call to increase access to care for the patients in their communities.”

Many of the patients who will be treated during this year’s Smile Generation Serve Day event are affiliated with After Innocence, a non-profit organization that serves prison exonerees nationwide – many of whom were falsely imprisoned for decades.

Dental practices supported by PDS have always taken precautions to ensure patient safety. However, in the midst of the COVID-19 pandemic, additional safety measures have been adopted to protect patients from the virus. In fact, dentists throughout the country have treated over half a million dental emergencies with no reports of COVID-19 infection traced to a dental practice, according to the Centers for Disease Control and Prevention. In an effort to build public confidence about the safety of dental practices, PDS-supported clinicians and dentists across the country launched a new grassroots campaign, #DentalSAFETY. For more information about the #DentalSAFETY campaign, click HERE.

The primary purpose of Pacific Dental Services is to support great dentists so they can focus on providing oral health care to their patients to keep them healthier and happier. This includes educating patients about the link between oral health and whole-body health – what PDS and its supported practices call the Mouth-Body Connection®. Research shows that harmful bacteria and inflammation in the mouth can indicate and even cause systemic conditions throughout the body. Maladies of the mouth, including periodontal disease, may be linked with other medical conditions including oral cancer, cardiovascular disease, diabetes, Alzheimer’s disease, rheumatoid arthritis, and more.

The Smile Generation’s annual campaign also includes local service projects. For more information, click here.

About Pacific Dental Services®

Founded in 1994, Pacific Dental Services (PDS) is one of the country’s leading dental support organizations, providing supported autonomy that enables dentists to concentrate on clinical excellence and the highest levels of cost-effective comprehensive patient care. PDS originated the Private Practice+® model to enable dentists to focus on their passion: serving patients. PDS also pioneered the concept of Modern Dentistry so that dentists are equipped to combine advances in the latest technology with the best operational practices and procedures, highly skilled support staff and a commitment to ongoing training and education. PDS continues to grow, with over 800 supported dental offices across the United States and plans to expand into several new markets. PDS supported dentists aim to be the provider of choice in all the markets they serve and to develop Patients for Life™.

For more information, visit us at https://www.pacificdentalservices.com

Facebook: https://www.facebook.com/PacificDentalServices/

LinkedIn: https://www.linkedin.com/company/293541/life/

Twitter: https://twitter.com/pacificdental

YouTube: https://www.youtube.com/user/PacificDentalTV

Young Innovations is excited to introduce Splatter Guard, an innovative new prophy angle that reduces splatter by up to 15 times* compared to traditional prophy angles.

Splatter Guard features a precisely engineered wiper just below the prophy cup designed to significantly reduce splatter without compromising the quality of the prophy angle. Nine out of 10 hygienists who tried Splatter Guard noticed a significant reduction or complete elimination of splatter.*

“The Splatter Guard prophy angle has been in development for more than 3 years, and the timing to launch in 2020 could not be more fitting,” said Ben Biesiada, Senior Marketing Manager for Young Innovations. “With heightened sensitivity around COVID-19, products that ensure a safer dental environment are more critical than ever.”

Splatter Guard disposable prophy angles are available in both Vera and Young Slim styles.

To LEARN MORE, please visit yng.ink/splatter-guard

About Young Innovations

Young Innovations (www.younginnovations.com) is a leading global provider of supplies and equipment used by dentists, hygienists, dental assistants and consumers. Our portfolio of brands includes products that hold leadership positions in the preventive, restorative, orthodontic and endodontic segments. With its mission of Creating Smiles, Creating Possibilities, Young focuses on delivering innovative, high-quality products and solutions to clinicians and their patients. We continue to enhance our portfolio of brands and products through organic growth and acquisitions.